📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Interim 2022/23 influenza vaccine effectiveness: six European studies, October 2022 to January 2023 (2023)

First Author: Kissling E

Attributed to: Early Assessment of COVID-19 epidemiology and Vaccine/anti-viral Effectiveness (EAVE II) funded by COVID

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.2807/1560-7917.es.2023.28.21.2300116

PubMed Identifier: 37227299

Publication URI: http://europepmc.org/abstract/MED/37227299

Type: Journal Article/Review

Parent Publication: Eurosurveillance

Issue: 21

ISSN: 1025-496X